[go: up one dir, main page]

DK226680A - Vaccine mod np-virus fremgangsmaade og midler til brug ved fremstilling deraf - Google Patents

Vaccine mod np-virus fremgangsmaade og midler til brug ved fremstilling deraf

Info

Publication number
DK226680A
DK226680A DK226680A DK226680A DK226680A DK 226680 A DK226680 A DK 226680A DK 226680 A DK226680 A DK 226680A DK 226680 A DK226680 A DK 226680A DK 226680 A DK226680 A DK 226680A
Authority
DK
Denmark
Prior art keywords
preparation
methods
vaccine against
virus procedure
virus
Prior art date
Application number
DK226680A
Other languages
Danish (da)
English (en)
Inventor
W J Rutter
H M Goodman
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26718684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK226680(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ California filed Critical Univ California
Publication of DK226680A publication Critical patent/DK226680A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DK226680A 1979-05-24 1980-05-23 Vaccine mod np-virus fremgangsmaade og midler til brug ved fremstilling deraf DK226680A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4190979A 1979-05-24 1979-05-24
US10726779A 1979-12-26 1979-12-26

Publications (1)

Publication Number Publication Date
DK226680A true DK226680A (da) 1980-11-25

Family

ID=26718684

Family Applications (1)

Application Number Title Priority Date Filing Date
DK226680A DK226680A (da) 1979-05-24 1980-05-23 Vaccine mod np-virus fremgangsmaade og midler til brug ved fremstilling deraf

Country Status (11)

Country Link
US (1) US5436139A (sh)
EP (1) EP0020251B1 (sh)
JP (2) JPH0659221B2 (sh)
CA (2) CA1341645C (sh)
DE (2) DE3072205T2 (sh)
DK (1) DK226680A (sh)
ES (1) ES8105388A1 (sh)
GR (1) GR68524B (sh)
IE (1) IE52036B1 (sh)
PT (1) PT71296B (sh)
YU (1) YU46343B (sh)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
EP0182442B2 (en) * 1978-12-22 1996-04-03 Biogen, Inc. Recombinant DNA molecules and their method of production
NZ192465A (en) * 1978-12-22 1983-09-30 Biogen Nv Recombinant dna molecule comprising gene coding for polypeptide displaying hbv (hepatitis b virus) antigenicity usesthereof
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4249952A (en) * 1980-03-03 1981-02-10 Pennsylvania Engineering Corporation Method for producing cement clinker from cement kiln waste dust
EP0038765B1 (fr) * 1980-04-22 1987-09-02 Institut Pasteur Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
EP0068719A3 (en) * 1981-06-16 1984-03-28 Takeda Chemical Industries, Ltd. Deoxyribonucleic acids, their production and use
US4769238A (en) 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
EP0340806B1 (en) * 1981-08-04 1995-05-31 The Regents Of The University Of California Synthesis of human virus antigens by yeast
GR76274B (sh) * 1981-08-04 1984-08-04 Univ California
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US4741901A (en) * 1981-12-03 1988-05-03 Genentech, Inc. Preparation of polypeptides in vertebrate cell culture
JPS58110600A (ja) * 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
US4508826A (en) * 1982-04-15 1985-04-02 Merck & Co., Inc. Bacteriophage DNA cloning vector TG1 and microorganisms containing TG1
US4460689A (en) * 1982-04-15 1984-07-17 Merck & Co., Inc. DNA Cloning vector TG1, derivatives, and processes of making
JPS5980615A (ja) * 1982-10-29 1984-05-10 Takeda Chem Ind Ltd Ｄｎａおよびその用途
US4703009A (en) * 1983-03-08 1987-10-27 Merck & Co., Inc. RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4859600A (en) * 1983-04-25 1989-08-22 Genentech, Inc. Recombinant procaryotic cell containing correctly processed human growth hormone
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US5204096A (en) * 1984-03-07 1993-04-20 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5158769A (en) * 1984-03-07 1992-10-27 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
EP0180012A1 (de) * 1984-10-27 1986-05-07 Wolfram H. Prof. Dr. Gerlich Immunogene Polypeptidsequenz des Hepatitis B-Virus
US7285271B1 (en) 1984-10-31 2007-10-23 Novartis Vaccines And Diagnostics, Inc. Antigenic composition comprising an HIV gag or env polypeptide
CA1341423C (en) 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US7273695B1 (en) * 1984-10-31 2007-09-25 Novartis Vaccines And Diagnostics, Inc. HIV immunoassays using synthetic envelope polypeptides
US7393949B1 (en) 1987-12-24 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Human immunodeficiency virus (HIV) nucleotide sequences
FI861417A0 (fi) * 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
JPH089637B2 (ja) * 1986-06-18 1996-01-31 財団法人阪大微生物病研究会 Ｂ型肝炎ウイルス抗原とその製造法
AU1668788A (en) * 1987-05-26 1988-12-01 Wistar Institute, The Method of vaccination for hepatitis b virus
WO1988010300A1 (en) * 1987-06-22 1988-12-29 Medico Labs Ag Heterologous viral peptide particle immunogens
EP0338620A1 (en) * 1988-04-18 1989-10-25 Merck & Co. Inc. Recovery of hepatitis B surface antigen
US4953930A (en) * 1989-03-15 1990-09-04 Ramtech, Inc. CPU socket supporting socket-to-socket optical communications
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US5928902A (en) * 1992-02-27 1999-07-27 Smithkline Beecham Biologicals (S.A.) Hybrid protein between CS from plasmodium and HBsAg
US5651568A (en) * 1992-10-09 1997-07-29 Gainsborough Hardware Industries, Limited Privacy snib mechanism
US6759193B2 (en) 1999-07-28 2004-07-06 The Government Of The Republic Of Singapore Detection of human hepatitis B virus surface antigen mutants by specific amplification and its application on gene chip

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
NZ192465A (en) * 1978-12-22 1983-09-30 Biogen Nv Recombinant dna molecule comprising gene coding for polypeptide displaying hbv (hepatitis b virus) antigenicity usesthereof
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes

Also Published As

Publication number Publication date
EP0020251A2 (en) 1980-12-10
IE800991L (en) 1980-11-24
JP2543751B2 (ja) 1996-10-16
JPS5663995A (en) 1981-05-30
DE20251T1 (de) 1986-02-27
CA1341645C (en) 2024-07-02
US5436139A (en) 1995-07-25
PT71296B (en) 1981-09-21
ES491832A0 (es) 1981-05-16
YU140380A (en) 1988-10-31
PT71296A (en) 1980-06-01
GR68524B (sh) 1982-01-11
YU46343B (sh) 1993-10-20
JPH0659221B2 (ja) 1994-08-10
EP0020251A3 (en) 1981-05-20
DE3072205T2 (de) 1993-08-05
ES8105388A1 (es) 1981-05-16
CA1341643C (en) 2023-02-28
EP0020251B1 (en) 1993-01-13
IE52036B1 (en) 1987-05-27
DE3072205D1 (de) 1993-02-25
JPH02450A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
DK226680A (da) Vaccine mod np-virus fremgangsmaade og midler til brug ved fremstilling deraf
DK304781A (da) Formdel og fremgansmaade til fremstolling heraf
DK358280A (da) Fremgangsmaade og midler til emballering
NO803330L (no) Elektrolysoer og fremgangsmaate for elektrolysering
DK385580A (da) Fremgangsmaade til pakning og pakkeapparat
NO801600L (no) Fremgangsmaate for fremstilling av et bindemiddel for betong og moertler.
DK263279A (da) Antiperspirant og fremgangsmaade til dets fremstilling
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
DK220380A (da) Vandigt koncentreret stofbloedgoeringsmiddel og fremgangsmaade til fremstilling deraf
NO150634C (no) Sementholdige blandinger og fremgangsmaate for deres fremstilling
DK131579A (da) Vandhaerdbar silanmodificeret alkylenalkylacrylatcopolymer og fremgangsmaade til dens fremstilling
NO151751C (no) Fremgangsmaate og innretning til forgasning av kull
NO791682L (no) Fornettbare copolymerer og fremgangsmaate ved fremstilling derav
DK531680A (da) Keramisk tandkrone og fremgangsmaade til fremstilling heraf
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
NO800094L (no) Fremgangsmaate ved utlegning av stroe og innretning for utfoerelse av fremgangsmaaten
DK98780A (da) Slettefjernelsesmiddel og fremgangsmaade til fremstilling deraf
DK251281A (da) N6-adenosiner og fremgangsmaader til deres fremstilling
DK158927C (da) Tandproteserensemiddel og fremgangsmaade til fremstilling deraf
DK271381A (da) Haardfedt og fremgangsmaade til fremstilling deraf
DK24280A (da) Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse
NO790047L (no) Kompoundmaterialer og fremgangsmaate til deres fremstilling
DK271281A (da) Haardfeldt og fremgangsmaade til fremstilling deraf
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
NO791520L (no) Substituerte antitumorantracycliner og fremgangsmaate for deres fremstilling

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment